» Authors » Mary E White-Scharf

Mary E White-Scharf

Explore the profile of Mary E White-Scharf including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 107
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ploemacher R, Johnson K, Rombouts E, Etienne K, Westerhof G, Baumgart J, et al.
Biol Blood Marrow Transplant . 2004 Apr; 10(4):236-45. PMID: 15077222
Treosulfan (L-threitol-1,4-bismethanesulfonate) is an alkylating agent with routine clinical application in the treatment of ovarian cancer. In this murine study we show that this drug also has the ability to...
2.
Andersson G, Denaro M, Johnson K, Morgan P, Sullivan A, Houser S, et al.
Mol Ther . 2003 Aug; 8(3):385-91. PMID: 12946311
We have investigated whether a state of tolerance toward EGFP-expressing skin tissue can be induced by prior establishment of EGFP molecular chimerism by transplant of gene-transduced bone marrow in mice....
3.
Andersson G, Illigens B, Johnson K, Calderhead D, LeGuern C, Benichou G, et al.
Blood . 2003 Feb; 101(11):4305-12. PMID: 12576326
Immunologic reactions against gene therapy products may prove to be a frequent problem in clinical gene therapy protocols. Enhanced green fluorescence protein (EGFP) is commonly used as a marker in...
4.
Down J, White-Scharf M
Stem Cells . 2003 Jan; 21(1):21-32. PMID: 12529548
Recent advances in cellular therapies have led to the emergence of a multidisciplinary scientific approach to developing therapeutics for a wide variety of diseases and genetic disorders. Although most cell-based...
5.
Buhler L, Chang Q, Abraham S, Alwayn I, Appel 3rd J, Newman D, et al.
Transplantation . 2002 Nov; 74(8):1159-66. PMID: 12438964
Background: The aim of the present study was to determine whether certain components of nonmyeloablative regimens for hematopoietic cell transplantation might compromise the growth of hematopoietic progenitors. Methods: Porcine peripheral...
6.
Giovino M, Down J, Jackson J, Sykes M, Monroy R, White-Scharf M
Transplantation . 2002 Mar; 73(5):723-31. PMID: 11907417
Background: Donor hematopoiesis is at a competitive disadvantage when bone marrow transplantation is across species barriers. This could present major limitations to xenogeneic stem cell transplantation as an approach to...
7.
Denaro M, Kolber-Simonds D, Schad V, Muthukumar S, Germana S, White-Scharf M, et al.
Xenotransplantation . 2002 Mar; 9(2):115-24. PMID: 11897004
We recently established that molecular chimeras of major histocompatibility complex (MHC) class II molecules, created via retroviral transfer of allogeneic class II cDNAs into bone marrow cells (BMCs), alleviated complications...
8.
Oldmixon B, Wood J, Ericsson T, Wilson C, White-Scharf M, Andersson G, et al.
J Virol . 2002 Feb; 76(6):3045-8. PMID: 11861871
Here we report the identification of inbred miniature swine that failed to produce human-tropic replication-competent porcine endogenous retroviruses (HTRC PERVs), using in vitro coculture assays. When HTRC PERVs were isolated...